Omega Therapeutics IncNASDAQ:OMGA
- LAST PRICE0.8284
- TODAY'S CHANGE (%)-0.1816 (-17.9802%)
- Bid / Lots0.8698/ 17
- Ask / Lots0.8700/ 8
- Open / Previous Close1.0100 / 1.0100
- Day Range
- 52 Week Range
- Volume1,365,246
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OMGA |
|---|---|---|
| 09:32 ET | 14801 | 1.0075 |
| 09:33 ET | 30569 | 0.98 |
| 09:35 ET | 11584 | 0.9751 |
| 09:39 ET | 11245 | 0.9601 |
| 09:42 ET | 33484 | 0.92 |
| 09:44 ET | 3100 | 0.92 |
| 09:46 ET | 13119 | 0.925 |
| 09:48 ET | 1225 | 0.9201 |
| 09:50 ET | 30728 | 0.911 |
| 09:51 ET | 36782 | 0.8901 |
| 09:53 ET | 2654 | 0.88 |
| 09:55 ET | 25158 | 0.860199 |
| 09:57 ET | 2920 | 0.8601 |
| 10:00 ET | 41091 | 0.815 |
| 10:02 ET | 3140 | 0.8269 |
| 10:04 ET | 1700 | 0.82 |
| 10:06 ET | 25728 | 0.8205 |
| 10:08 ET | 31766 | 0.8112 |
| 10:09 ET | 39500 | 0.81 |
| 10:11 ET | 24236 | 0.81 |
| 10:13 ET | 27515 | 0.7932 |
| 10:15 ET | 24630 | 0.8008 |
| 10:18 ET | 7761 | 0.8085 |
| 10:20 ET | 16622 | 0.7994 |
| 10:22 ET | 4897 | 0.7954 |
| 10:24 ET | 8543 | 0.7935 |
| 10:26 ET | 2544 | 0.7906 |
| 10:27 ET | 700 | 0.79495 |
| 10:29 ET | 1600 | 0.790601 |
| 10:31 ET | 5262 | 0.7994 |
| 10:33 ET | 22674 | 0.7994 |
| 10:36 ET | 12417 | 0.8187 |
| 10:38 ET | 7319 | 0.8298 |
| 10:40 ET | 5995 | 0.8339 |
| 10:42 ET | 2009 | 0.8419 |
| 10:44 ET | 20900 | 0.841759 |
| 10:45 ET | 703 | 0.843 |
| 10:47 ET | 7373 | 0.83 |
| 10:49 ET | 1086 | 0.825 |
| 10:51 ET | 7410 | 0.835 |
| 10:54 ET | 300 | 0.835 |
| 10:56 ET | 300 | 0.825 |
| 11:00 ET | 890 | 0.84 |
| 11:02 ET | 120 | 0.8444 |
| 11:03 ET | 7755 | 0.84 |
| 11:05 ET | 100 | 0.825 |
| 11:07 ET | 500 | 0.8404 |
| 11:09 ET | 100 | 0.825 |
| 11:14 ET | 1350 | 0.8403 |
| 11:16 ET | 3722 | 0.83 |
| 11:20 ET | 5290 | 0.84 |
| 11:21 ET | 1354 | 0.84 |
| 11:23 ET | 15540 | 0.824 |
| 11:25 ET | 67624 | 0.8 |
| 11:27 ET | 6031 | 0.800001 |
| 11:30 ET | 6146 | 0.8053 |
| 11:32 ET | 2109 | 0.8001 |
| 11:34 ET | 850 | 0.8 |
| 11:36 ET | 2234 | 0.7998 |
| 11:38 ET | 2276 | 0.794 |
| 11:39 ET | 100 | 0.794 |
| 11:41 ET | 4357 | 0.794 |
| 11:43 ET | 1929 | 0.7942 |
| 11:45 ET | 13567 | 0.798 |
| 11:48 ET | 400 | 0.79 |
| 11:50 ET | 4716 | 0.798099 |
| 11:52 ET | 540 | 0.7916 |
| 11:54 ET | 738 | 0.7951 |
| 11:56 ET | 100 | 0.7985 |
| 11:57 ET | 1100 | 0.7916 |
| 11:59 ET | 725 | 0.7916 |
| 12:01 ET | 3500 | 0.795 |
| 12:03 ET | 1769 | 0.7942 |
| 12:06 ET | 100 | 0.7985 |
| 12:10 ET | 5184 | 0.79425 |
| 12:12 ET | 2599 | 0.79 |
| 12:14 ET | 645 | 0.79425 |
| 12:15 ET | 1373 | 0.79425 |
| 12:17 ET | 713 | 0.7907 |
| 12:19 ET | 1000 | 0.7965 |
| 12:21 ET | 15721 | 0.7926 |
| 12:24 ET | 5124 | 0.78525 |
| 12:26 ET | 32688 | 0.78 |
| 12:28 ET | 8487 | 0.78 |
| 12:30 ET | 800 | 0.7852 |
| 12:32 ET | 275 | 0.7904 |
| 12:33 ET | 3709 | 0.78515 |
| 12:35 ET | 8657 | 0.78515 |
| 12:39 ET | 1400 | 0.78515 |
| 12:44 ET | 200 | 0.790299 |
| 12:48 ET | 371 | 0.78515 |
| 12:50 ET | 14100 | 0.7802 |
| 12:51 ET | 10428 | 0.8004 |
| 12:53 ET | 545 | 0.7998 |
| 12:55 ET | 41365 | 0.8135 |
| 12:57 ET | 2691 | 0.8146 |
| 01:00 ET | 500 | 0.822 |
| 01:02 ET | 6013 | 0.82 |
| 01:04 ET | 1003 | 0.82 |
| 01:06 ET | 34960 | 0.83 |
| 01:08 ET | 1030 | 0.825 |
| 01:09 ET | 1671 | 0.8299 |
| 01:11 ET | 320 | 0.8396 |
| 01:13 ET | 5600 | 0.8317 |
| 01:15 ET | 1150 | 0.8201 |
| 01:18 ET | 810 | 0.8237 |
| 01:20 ET | 3500 | 0.8201 |
| 01:24 ET | 1600 | 0.8234 |
| 01:26 ET | 800 | 0.825 |
| 01:27 ET | 7202 | 0.83 |
| 01:29 ET | 500 | 0.8301 |
| 01:31 ET | 5100 | 0.8308 |
| 01:33 ET | 340 | 0.8309 |
| 01:36 ET | 685 | 0.8251 |
| 01:38 ET | 600 | 0.8201 |
| 01:40 ET | 342 | 0.83 |
| 01:42 ET | 1930 | 0.8201 |
| 01:44 ET | 200 | 0.82 |
| 01:45 ET | 140 | 0.82 |
| 01:47 ET | 275 | 0.82505 |
| 01:49 ET | 300 | 0.82505 |
| 01:51 ET | 210 | 0.82 |
| 01:54 ET | 728 | 0.82 |
| 01:56 ET | 9699 | 0.815 |
| 01:58 ET | 19590 | 0.8151 |
| 02:00 ET | 6468 | 0.8151 |
| 02:02 ET | 100 | 0.8113 |
| 02:03 ET | 5940 | 0.8151 |
| 02:07 ET | 3476 | 0.815699 |
| 02:09 ET | 1791 | 0.82 |
| 02:12 ET | 29600 | 0.8114 |
| 02:14 ET | 700 | 0.8114 |
| 02:16 ET | 200 | 0.8113 |
| 02:18 ET | 927 | 0.8101 |
| 02:20 ET | 100 | 0.8102 |
| 02:21 ET | 4933 | 0.8102 |
| 02:25 ET | 350 | 0.81015 |
| 02:27 ET | 2000 | 0.8102 |
| 02:30 ET | 200 | 0.8102 |
| 02:32 ET | 1424 | 0.81015 |
| 02:34 ET | 100 | 0.8102 |
| 02:36 ET | 177 | 0.8102 |
| 02:38 ET | 5699 | 0.8103 |
| 02:45 ET | 300 | 0.8284 |
Nov 15, 2024
DJ Omega Therapeutics Is Maintained at Overweight by Piper Sandler, from 7:55AM ET on Friday Nov 15, 2024 by Dow Jones
7:55AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
DJ Omega Therapeutics Names Kaan Certel as CEO, from 5:28PM ET on Thursday Nov 14, 2024 by Dow Jones
5:28PM ET on Thursday Nov 14, 2024 by Dow JonesOmega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
4:05PM ET on Thursday Nov 14, 2024 by Dow JonesPress Release: Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
4:05PM ET on Thursday Nov 14, 2024 by Dow Jones
Oct 23, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omega Therapeutics Inc | 45.7M | -0.6x | --- |
OncoCyte Corp | 43.9M | -0.6x | --- |
Dyadic International Inc | 33.3M | -5.2x | --- |
Lumos Pharma Inc | 37.4M | -1.0x | --- |
Provectus Biopharmaceuticals Inc | 46.2M | -16.6x | --- |
BioLine RX Ltd | 39.8M | -0.6x | --- |
Company Information
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in the development of a programmable epigenomic mRNA medicine to treat or cure a broad range of diseases. The Company’s OMEGA platform has enabled it to identify and validate various DNA-sequence-based epigenomic, zip codes, associated with individual regulatory elements within Insulated Genomic Domains (IGDs). The Company designs and engineers its mRNA therapeutics, called epigenomic controllers, or ECs, to target EpiZips for precision epigenomic control. Its pipeline consists of programs that span oncology, regenerative medicine, and multigenic diseases including immunologic and cardiometabolic conditions. The Company’s precision epigenomic control delivered by the OMEGA platform has therapeutic applicability and transformational potential, spanning across oncology, multigenic diseases including immunologic and cardiometabolic conditions, and regenerative medicine.
Contact Information
- Headquarters
- 140 First Street, Suite 501CAMBRIDGE, MA, United States 02141
- Phone
- 617-949-4360
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Christian Schade
- President, Chief Executive Officer, Director
- Kaan Certel
- Principal Financial Officer, Senior Vice President - Finance, Principal Accounting Officer
- Barbara Chan
- Chief Legal and Administrative Officer
- Ling Zeng
- Chief Scientific Officer
- Jennifer Nelson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $45.7M |
|---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.77 |
EPS | $-1.33 |
Book Value | $1.05 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -916.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
